Sleep architecture as correlate and predictor of symptoms and impairment in inter-episode bipolar disorder: taking on the challenge of medication effects.
This study was designed to clarify the association between inter-episode bipolar disorder (BD) and sleep architecture. Participants completed a baseline symptom and sleep assessment and, 3 months later, an assessment of symptoms and impairment. The effects of psychiatric medications on sleep architecture were also considered. Participants included 22 adults with BD I or II (inter-episode) and 22 non-psychiatric controls. The sleep assessment was conducted at the Sleep and Psychological Disorders Laboratory at the University of California, Berkeley. Follow-up assessments 3 months later were conducted over the phone. Results indicate that, at the sleep assessment, BD participants exhibited greater rapid eye movement sleep (REM) density than control participants with no other group differences in sleep architecture. Sleep architecture was not correlated with concurrent mood symptoms in either group. In the BD group, duration of the first REM period and slow-wave sleep (SWS) amount were positively correlated with manic symptoms and impairment at 3 months, while REM density was positively correlated with depressive symptoms and impairment at 3 months. The amount of Stage 2 sleep was negatively correlated with manic symptoms and impairment at 3 months. In contrast, for the control group, REM density was negatively correlated with impairment at 3 months. SWS and Stage 2 sleep were not correlated with symptoms or impairment. Study findings suggest that inter-episode REM sleep, SWS and Stage 2 sleep are correlated with future manic and depressive symptoms and impairment in BD. This is consistent with the proposition that sleep architecture may be a mechanism of illness maintenance in BD.
Eidelman
Polina
P
Department of Psychology, University of California, Berkeley, CA 94720-1650, USA.
Talbot
Lisa S
LS
Gruber
June
J
Hairston
Ilana
I
Harvey
Allison G
AG
D000328:Adult; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017286:Polysomnography; D012890:Sleep / Q000187:drug effects / Q000502:physiology; D012893:Sleep Wake Disorders / Q000150:complications* / Q000209:etiology / Q000503:physiopathology; D012895:Sleep, REM / Q000187:drug effects / Q000502:physiology; D055815:Young Adult
D018692:Antimanic Agents
Br J Psychiatry. 2002 May;180:461-4
11983645
Am J Psychiatry. 1982 May;139(5):571-6
7072840
Biol Psychiatry. 1986 May;21(5-6):465-72
3697436
Sleep. 1993 Feb;16(2):100-13
8446828
Eur Neuropsychopharmacol. 2007 Jul;17(8):527-31
17337164
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):22-9
16048734
Psychiatr Serv. 2006 May;57(5):660-5
16675760
Pharmacol Biochem Behav. 2007 Mar;86(3):468-76
17303232
J Exp Psychol Gen. 1994 Jun;123(2):201-15
8014613
Arch Gen Psychiatry. 2002 Jun;59(6):530-7
12044195
Psychiatry Res. 1987 Jun;21(2):89-94
3615694
Int J Neuropsychopharmacol. 2004 Sep;7(3):275-81
15122973
J Affect Disord. 2003 Apr;74(2):173-84
12706519
Hum Neurobiol. 1982;1(3):195-204
7185792
J Affect Disord. 2002 Aug;70(3):273-80
12128239
Psychiatry Res. 1998 Sep 21;80(3):249-55
9796940
Psychol Med. 1996 May;26(3):477-86
8733206
Psychopharmacology (Berl). 2007 Mar;190(4):507-16
17205319
Psychopharmacology (Berl). 2001 Mar 1;154(2):189-97
11314681
Sleep Med. 2003 Jan;4(1):51-5
14592360
Am J Psychiatry. 2008 Jul;165(7):820-9
18519522
Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):61-8
15146334
Biol Psychiatry. 1986 Nov;21(13):1340-3
3756280
J Clin Psychopharmacol. 1994 Feb;14(1):36-40
7512100
Sleep. 1987 Oct;10(5):443-51
3685752
J Affect Disord. 2003 May;74(3):209-17
12738039
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
15939839
Psychopharmacology (Berl). 1989;98(1):139-40
2498958
Psychopharmacology (Berl). 2004 Jul;174(3):421-9
15029469
Sleep. 2000 Feb 1;23(1):87-95
10678469
Br J Psychiatry. 1978 Nov;133:429-35
728692
Arch Gen Psychiatry. 1992 Aug;49(8):651-68; discussion 669-70
1386215
Epilepsy Behav. 2000 Dec;1(6):378-383
12737827
Biol Psychiatry. 1998 Jul 1;44(1):3-14
9646878
Behav Brain Res. 2008 Mar 5;187(2):254-61
17964671
Neuropsychobiology. 2005;51(4):214-25
15915004
Sleep Med Rev. 2003 Oct;7(5):423-40
14573378
Biol Psychiatry. 2005 Nov 1;58(9):694-9
16018976
Arch Gen Psychiatry. 1992 May;49(5):378-83
1586273
Psychopharmacology (Berl). 1994 Dec;116(4):389-95
7701038
Am J Psychiatry. 1998 Feb;155(2):192-9
9464197
Sleep. 2006 Mar;29(3):307-16
16553016
Psychopharmacol Bull. 1996;32(4):637-46
8993085
J Psychiatr Res. 2000 Nov-Dec;34(6):423-38
11165310
Am J Psychiatry. 2008 Mar;165(3):313-20
18245175
Am J Physiol. 1996 Sep;271(3 Pt 2):R501-10
8853369
Pharmacopsychiatry. 1987 Jan;20(1):23-9
3823126
Sleep. 2003 May 1;26(3):313-7
12749551
Sleep. 2005 Jul;28(7):829-36
16124661
Bipolar Disord. 2006 Jun;8(3):271-4
16696829
Arch Gen Psychiatry. 1988 Mar;45(3):267-73
3341881
Neuropsychopharmacology. 2002 Apr;26(4):530-6
11927177
Int J Clin Pharmacol Res. 1989;9(3):183-95
2568348
Can J Psychiatry. 1986 May;31(4):295-8
3708522
Am J Psychiatry. 1987 Feb;144(2):201-4
3812788
Biol Psychiatry. 1997 Aug 15;42(4):260-6
9270902
J Clin Psychopharmacol. 2003 Dec;23(6):540-8
14624183
Curr Biol. 2007 Oct 23;17(20):R877-8
17956744
Sleep. 2004 Dec 15;27(8):1567-96
15683149